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Natural and synthetic phenazines are widely used in biomedical sciences. In dehydrogenase histochemistry,
phenazine methosulfate (PMS) is applied as a redox reagent for coupling reduced coenzymes to the reduction of
tetrazolium salts into colored formazans. PMS is also currently used for cytotoxicity and viability assays of cell
cultures using sulfonated tetrazoliums. Under UV (340 nm) excitation, aqueous solutions of the cationic PMS
show green fluorescence (λem: 526 nm), whereas the reduced hydrophobic derivative (methyl-phenazine, MPH)
shows blue fluorescence (λem: 465 nm). Under UV (365 nm) excitation, cultured cells (LM2, IGROV-1, BGC-1, and
3T3-L1 adipocytes) treated with PMS (5 μg/mL, 30 min) showed cytoplasmic granules with bright blue fluo-
rescence, which correspond to lipid droplets labeled by the lipophilic methyl-phenazine. After formaldehyde
fixation blue-fluorescing droplets could be stained with oil red O. Interestingly, PMS-treated 3T3-L1 adipocytes
observed under UV excitation 24 h after labeling showed large lipid droplets with a weak green emission within a
diffuse pale blue-fluorescing cytoplasm, whereas a strong green emission was observed in small lipid droplets.
This fluorescence change from blue to green indicates that reoxidation of methyl-phenazine to PMS can occur.
Regarding cell uptake and labeling mechanisms, QSAR models predict that the hydrophilic PMS is not signifi-
cantly membrane-permeant, so most PMS reduction is expected to be extracellular and associated with a plasma
membrane NAD(P)H reductase. Once formed, the lipophilic and blue-fluorescing methyl-phenazine enters live
cells and mainly accumulates in lipid droplets. Overall, the results reported here indicate that PMS is an excellent
fluorescent probe to investigate labeling and redox dynamics of lipid droplets in cultured cells.1. Introduction
Phenazine methosulfate (PMS) was first synthesized by Kehrmann
and Havas (1913) [1] from phenazine and dimethylsulfate. Later it was
applied in dehydrogenase histochemistry [2, 3, 4, 5], and studies on the
photosynthesis of bacteria [6].
The hydrophilic cation PMS is now widely used as an intermediate
redox reagent for coupling reduced dehydrogenase coenzymes to theockert), dlombard@fvet.uba.ar (D
27 May 2020; Accepted 5 June 2
vier Ltd. This is an open access arreduction of tetrazolium salts into colored formazans [7, 8, 9, 10, 11, 12,
13, 14]. A similar electron-transfer agent, 1-methoxy-PMS, has also been
used for revealing dehydrogenase activity in living hepatocytes [15].
Other similar but seldom scarcely used redox intermediates are Meldola
blue, menadione, and pyocyanin.
In addition, PMS is also applied in cytotoxicity and viability assays of
cell cultures, using sulfonated tetrazoliums such as MTS, WST-1, WST-8,
and XTT [16, 17, 18, 19, 20]. PMS also accelerates the reduction of MTT.M. Lombardo).
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living cells cannot be ruled out since this compound inhibits oxidative
phosphorylation [22], and is mutagenic in Escherichia coli and Salmonella
typhimurium assays [23].
The yellow PMS is capable of oxidizing NADH, passing electrons to
tetrazolium salts [5]. PMS is reduced by flavoproteins (succinic dehy-
drogenase), and non-enzymatically by NAD(P)H, ascorbic acid, vitamin
K, reduced ubiquinones, dithionite, and sodium borohydride [24]. The
reduced PMS (methyl-phenazine, MPH) is colorless and easily reoxidized
by oxygen or via the respiratory chain, and the reaction is blocked by
inhibitors of cytochrome oxidase such as cyanide ions [22].
Methyl-phenazine is hydrophobic and has low solubility in aqueous
media [12]. The chemical structures of PMS and methyl-phenazine are
shown in Figure 1.
Interestingly, both natural and synthetic phenazines have important
applications in biomedical sciences [25]. Examples include the blue
pigment pyocyanin from Pseudomonas aeruginosa [26], and several azine
dyes such as Janus green B, neutral red, and safranine O [27]. There are
also phenazine derivatives with antibacterial, antileukemic, antimycotic,
antiparasitic, antitubercular, and antitumoral activities, as well com-
pounds with immune-suppressive, and biofilm-eradicating properties
[28, 29, 30, 31, 32, 33, 34]. Massive accumulation of crystal-like in-
clusions of the antileprosy phenazine, clofazimine, within live macro-
phages have been described [35]. In a similar way to what occurs with
some oxidized and reduced thiazine dyes [36], the redox
PMS-methyl-phenazine cycling activity could be partially responsible of
cytotoxic and antitumoral effects of some phenazine derivatives.
According to traditional color theory, PMS is not a dye as it lacks an
auxochrome group [37], and perhaps as a consequence, its fluorescence
properties and possible interactions with biological substrates within
living cells have been largely overlooked. A few exceptions to this can be
cited. A chemiluminescence flash induced by PMS in the presence of
H2O2 and reductants (NADH, ascorbic acid) was observed instrumen-
tally, possibly involving the green semiquinone PMS cation [38]. Spec-
troscopic studies on PMS absorption are known [26, 39, 40], but
emission properties and possible uses of PMS and derivatives as labeling
probes have been overlooked in fluorescence microscopy.
Here we report a previously unnoticed, unexpected redox-dependent
bright blue fluorescence of cytoplasmic granules, corresponding to lipid
droplets, in different cultured cell lines after treatment with PMS. This
constitutes an experimental basis for using this compound as a novel
fluorescent probe to study the labeling and redox dynamics of lipid
droplets.
2. Material and methods
2.1. Chemicals
PMS (5-methylphenazinium methyl sulfate, phenazine methosulfate)
was purchased from Sigma-Aldrich (P9625, St. Louis, USA; purity: 98%),
and used as received. Milli-Q water was obtained from a Milli-Q system
(Millipore). Zinc powder, acetic acid, and n-octanol were obtained fromFigure 1. Chemical structures of phenazine methosulfate in its oxidized cationic
form (PMS), and the reduced derivative (methyl-phenazine). The incorporation
of a hydrogen at the N atom of the central ring in PMS leads to a lower delo-
calization of the electrons, resulting in a color loss of methyl-phenazine.
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Sigma–Aldrich (Darmstadt, Germany). The copolymer Tetronic® 1107
(Ethylenediaminetetrakis (propoxylate-block-ethoxylate)tetrol-polox-
amine) was obtained from BASF (MW: 15 kDa, New Jersey, USA). The
reduction of aqueous PMS solutions to methyl-phenazine was accom-
plished using Zn powder at acid pH. PMS (2 mg, 0.0065 mmol) was
dissolved in Milli-Q water (4 mL) previously acidified with acetic acid
(0.1 mL). Finely powdered Zn (10 mg, 0.153 mmol) was added slowly at
room temperature (RT). After complete addition, the mixture was stirred
at RT until the yellow color disappeared (0.5 h), then filtered under
argon, extracted with n-octanol (3  3 mL), and the organic phase
immediately used to prepare a dilution in order to record the emission
spectra. The solution obtained was maintained in the argon atmosphere
until all the measurements were made. The polymeric micelle solution
(10%w/v) was prepared by dissolving the required amount of copolymer
T1107 in milli-Q water (pH 7–8) at 4 C followed by the equilibration of
the system at 25 C for at least 24 h before use [41], in order to obtain the
emission spectra of methyl-phenazine in the lipophilic T1107 micelles.
2.2. Spectroscopy
Emission spectra were obtained using fluorescence spectrofluorome-
ters LS55 (Perkin Elmer, Waltham, USA), and PTI Quanta Master QM4
((PhotoMed GmbH, Seefeld, Germany), using a 10  10 mm quartz
cuvette. All experiments were performed at RT. The emission spectra of
of aqueous PMS and methyl-phenazine in water, n-octanol and T1107
micelles were collected at an excitation wavelength of 340 nm and
recorded between 350 nm and 750 nm.
To estimate lipophilic/hydrophilic properties, the logarithm of the
octanol-water partition coefficient (log P) of PMS and methyl-phenazine
was determined by the traditional shake-flask method at RT [42]. MilliQ
water and n-octanol were mutually saturated. After saturation, a known
amount of drug was loaded into the aqueous phase such that the con-
centration of the final dilutions lies in the range of developed analytical
UV method. Equal amounts of a drug-loaded aqueous phase and
n-octanol were shaken together on a mechanical shaker for 30 min,
centrifuged at 3000 rpm for 15 min to afford complete phase separation,
and the n-octanol phase was removed. The absorbance of the water phase
was measured spectrophotometrically at the corresponding λmax. Also,
log P values were calculated by using two different fragment methods,
namely those of Hansch and Leo [43] and Black and Mould [44]. Log P
values were then inserted into predictive QSAR models [45, 46, 47] to
evaluate probable cellular uptake and intracellular localization of both
PMS and methyl-phenazine. Note that this procedure used the log P
values provided by the Hansch and Leo method [43], as the QSARmodels
required log P values only available from this system.
2.3. Cell cultures and treatments
The cultured cells, LM2 (murine mammary adenocarcinoma, Instituto
Roffo, Buenos Aires, Argentina), IGROV-1 (human ovary carcinoma,
ATCC), BGC-1 (bovine ovarian granulosa), and activated mouse 3T3-L1
adipocytes were used for microscopic labeling assessment by PMS. In
the case of BGC-1, both cells and follicular fluid were obtained by
puncturing ovarian follicles 3–8 mm in the size of cows and heifers after
slaughter. Cells from the primary BGC-1 culture were grown on 18  18
mm coverslips in multiwell plates in culture medium DMEM þ F12 (pH
7.4) supplemented with 5% fetal calf serum, 2 nM L-glutamine, and an-
tibiotics as previously described [48]. Cells from passage 8 were used for
PMS labeling. Murine preadipocyte 3T3-L1 fibroblasts were differenti-
ated to adipocytes by induction for 5 days after seeding with 0.1 μM
dexamethasone, 0.5 mM isobutyl methyl xanthine (IBMX; Sigma I-7018),
and 2 μM insulin (Bovine; Sigma I-5500), followed by additional treat-
ment with insulin alone for 3 days. The induction procedure was per-
formed following protocols slightly modified [49, 50].
All cell cultures were treated with PMS (from 5 to 20 μg/mL for 15
min to 3 h), washed, and mounted with PBS. Observations were made
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Japan), and Leica DM4000B Led (Wetzlar, Germany), under ultraviolet
(UV, 365 nm) and blue (436 nm) exciting light. To test the possible
reduction to methyl-phenazine directly induced by the culture medium,
PMS at a final concentration of 50 μg/mL was added to the complete
culture medium (at 37 C, in the absence of cells and pH indicator) and
observed 30 min later. In some cases, cell cultures were fixed with 4%
aqueous formaldehyde before PMS treatment. To confirm the lipid nature
of labeled droplets, formaldehyde-fixed 3T3-L1 adipocytes were fixed in
4% aqueous formaldehyde and stained with 0.36%w/v oil red O (Sigma-
Aldrich) solution in 40% v/v isopropanol for 60 min after PMS treatment.
The samples were washed in distilled water, counterstained with Mayer's
hematoxylin for 10 min, washed with tap water, and mounted in a drop
of gum Arabic solution (Winsor & Newton, London, UK). In other cases,
adipocytes were allowed to grow for an additional 24 h in complete
medium and then observed under UV and blue excitation.
Colorimetric viability assays [51, 52] were performed by triplicate on
nearly confluent LM2 cells (24 h post PMS incubation at different con-
centrations for 30 min), using 50 μg/mL MTT for 3 h, followed by for-
mazan extraction with DMSO, and reading at 560 nm in an Epoch
microplate spectrophotometer (Biotek, Winooski, USA). Cell survival was
expressed as the percentage of formazan absorbance of treated cells in
comparison with that of control cells.
3. Results
The emission spectra of PMS and methyl-phenazine are shown in
Figure 2. Under 340-nm excitation, PMS in distilled water showed a
green fluorescence with an emission peak at 526 nm, whereas the fluo-
rescence of methyl-phenazine was blue with an emission peak at 465,
466, and 469 nm in water, T1107 and n-octanol, respectively. After
reducing PMS to methyl-phenazine, a large blue-shifted absorption (61
nm) band is observed as consequence of the conjugation disruption
present in the molecule (not shown). It must be noted that non-
normalized emission spectra of samples with similar concentration
(around 3 μM) show an increment of almost 10 times in the fluorescenceFigure 2. Normalized emission spectra of PMS in water, and methyl-phenazine
(MPH) in n-octanol, lipophilic micelles (T1107) and water.
Table 1. Log P values of PMS and methyl-phenazine obtained using different method
PMS and methyl-phenazine, respectively.
Log P values
Experimental
Calculated by Hansch and Leo (1995) procedure [43]
Calculated by Black and Mould (1991) procedure [44]
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intensity of methyl-phenazine dissolved in a lipophilic solvent as
compared with PMS in water (not shown).
The hydrophilic/lipophilic comparison of PMS and methyl-phenazine
is indicated by the experimental and calculated log P values shown in
Table 1. Although the log P values for each compound vary with the
method of estimation, nevertheless, the oxidized PMS cation is consis-
tently more hydrophilic than the reduced derivative, methyl-phenazine.
The QSAR models predict [45, 46] that the hydrophilic PMS cation is
not membrane-permeant, and therefore it is expected to remain outside
the plasma membrane. However, the uncharged and lipophilic
methyl-phenazine is predicted to enter into live cells and localize in lipid
components, in particular lipid droplets and the Golgi apparatus. Since
methyl-phenazine is non-ionic, has a log P < 5, and is not amphiphilic,
significant accumulation in other cell membranes is not expected.
Viability assays were carried out on LM2 cells using the MTT method.
With a 30 min incubation, a dose-dependent loss of viability occurred at
24 h when the PMS concentration exceeded 5 μg/mL (Figure 3).Under
UV exciting light, fluorescence microscopy of all cell cultures subjected to
PMS treatments showed a bright blue granular labeling pattern within
the cytoplasm (Figure 4). Generally, some weak and diffuse blue fluo-
rescence was also found in the cytoplasm, but see below; nuclei were
non-fluorescent. When observed under bright-field illumination, lipid
droplets appeared as highly refringent vacuoles within the cytoplasm of
both control and PMS-treated adipocytes (Figure 5, A). As shown by
fluorescence microscopy after PMS treatment, lipid droplets were the
only cell component with a strong and selective blue labeling (Figure 5,
B, C). In 3T3-L1 cells stained with oil red O, this component showed a red
color, which indicates its lipid character (Figure 5, D). Colocalization
studies of the methyl-phenazine signal and fluorescent lipid probes such
as Nile red and oil red O were not made in living cells because excitation
of these probes by the blue emission of methyl-phenazine could generate
misleading results. The Golgi apparatus of LM2, IGROV-1, and BGC-1
cells was also slightly labeled, but in 3T3-L1 adipocytes, the intense la-
beling of large lipid droplets hindered the precise observation of this
organelle.
UV-induced blue fluorescence of lipid droplets was clearly observed
with all PMS concentrations and incubation times used, although 5 μg/
mL and 30 min were the optimal conditions for cell viability and bright
selective labeling of lipid droplets. Some fading was observed after PMS
labeling, which did not impede the detailed observation of cells. No blue
fluorescence was found in any structure in cells previously fixed with
formaldehyde. In addition, no discoloration of the yellow PMS was
observed in the presence of culture medium alone in vitro. With blue
excitation (436 nm), the emission of lipid droplets was pale green. 3T3-
L1 adipocytes treated with 5 μg/mL PMS for 30 min and observed 24 h
later under UV excitation showed a striking change of emission color in
lipid droplets (Figure 6). In this case, weak green fluorescence was found
in large lipid droplets, which were surrounded by a clear blue rim within
a diffuse pale blue-fluorescing cytoplasm. Small lipid droplets with a
strong green fluorescence were commonly observed in PMS-treated cells
(Figure 6).
4. Discussion
When reduced, several dyes - including methylene blue, Janus green
B, and ethidium bromide - become colorless or show changes in their





Figure 3. MTT viability at 24 h of LM2 cells following 30 min PMS treatment at
different concentrations. Mean  SD values from at least three different assays
are shown.
Figure 4. Fluorescence micrographs of cultured LM2 cells (A) and IGROV-1
cells (B) after treatment with PMS (5 μg/mL for 30 min), showing the bright
blue emission of lipid droplets (arrows) under 365-nm excitation. N: nuclei.
Figure 5. A: unstained 3T3-L1 adipocytes observed under bright-field illumi-
nation, showing refringent lipid droplets (arrows). B, C: fluorescence images of
3T3-L1 adipocytes treated with PMS (5 μg/mL, 30 min), showing the selective
blue labeling of lipid droplets (arrows). N: nuclei. Note the binucleate cells in C
(intracellular dark circles). UV (365 nm) excitation. D: Bright-field image of
3T3-L1 adipocytes fixed in formaldehyde and stained with oil red O, showing
the positive staining of lipid droplets (arrows). Mayer’ hematoxylin
counterstaining.
Figure 6. 3T3-L1 adipocytes treated with PMS (5 μg/mL, 30 min), maintained
in DMEM for 24 h, and then observed under 365-nm excitation. Within the blue
cell cytoplasm, large lipid droplets show a greenish fluorescent core surrounded
by a blue rim (large arrows), whereas small droplets have a bright green
emission (small arrows). N: nuclei.
J.C. Stockert et al. Heliyon 6 (2020) e04182blue and non-fluorescent indigo carmine to the green-fluorescing leu-
co-compound [54]. The present investigation shows that after reduction,
the green emission color of PMS changes to a blue emission from
methyl-phenazine, which is the only observed short-term microscopic
fluorescence in live cells after PMS treatments.
Regarding possible mechanisms of labeling, as the hydrophilic PMS is
expected to be plasmatic membrane non-permeant, most PMS will
remain in the cell culture medium. In this case, as extracellular PMS
reduction by the culture medium itself does not occur, reduction is likely
to be associated with biochemical processes at the cell surface of living
cells, plausibly due to a plasma membrane-bound NAD(P)H reductase
[55, 56], which has been proposed to be the NAD(P)H: quinone oxido-
reductase 1 (NQO1) [36]. The resulting lipophilic and blue-fluorescing
methyl-phenazine will then enter into live cells by passive diffusion
through the plasma membrane, followed by accumulation within lipid
droplets and the Golgi apparatus (Figure 7). Note that on account of the4
strong reducing power of the cytoplasm [53, 57], which is due to the
abundance of reduced NAD(P)H and dehydrogenases, methyl-phenazine
will remain reduced, providing suitable stability for the selective blue
fluorescence of lipid structures.
However, 24 h after PMS labeling of 3T3-L1 adipocytes, the emission
color of lipid droplets had changed from blue to green, indicating that
reoxidation to PMS can occur. It is tempting to speculate that the gradient
of blue-to-green color change shown by lipid droplets is related to a
decrease of reducing power or to an increase of oxidative stress, perhaps
even driven by PMS- methyl-phenazine redox cycling (see Figure 3 for
MTT cell viability assay). Reducing conditions are present in the cyto-
plasm, while molecular oxygen dissolves better in lipophilic environ-
ments, like the core of the lipid droplets. Therefore, a PMS- methyl-
phenazine loaded lipid droplet redox cycle can be formed, in which
Figure 7. Scheme illustrating the possible molecular reduction mechanism of
PMS at the plasma membrane of live cells, and subsequent labeling of a lipid
droplet by methyl-phenazine. The reduced coenzyme NAD(P)H provides
hydrogen (H) to the coenzyme Q, and then to PMS by the activity of the enzyme
NQO1 (NAD(P)H:quinone oxidoreductase 1). In cell viability assays, the extra-
cellular methyl-phenazine reduces sulfonated tetrazolium salts to
colored formazans.
J.C. Stockert et al. Heliyon 6 (2020) e04182PMS remains reduced to methyl-phenazine at the droplet-cytoplasm
interface, and then the reduced product diffuses to the core where it is
reoxidized to PMS by electron transfer to molecular oxygen. Tentatively,
this can lead to reactive oxygen species (ROS) generation at the lipid
droplet core. The ultimate fate of these ROS is speculative, but it could
explain the observed decrease in cell viability at high PMS concentrations
(see Figure 3). Ongoing research is devoted to ROS detection after PMS
cell incubation.
QSAR modeling of cell uptake and intracellular localization supports
these conclusions. According to QSAR models [46] the sulfonated
tetrazolium salts MTS, WSR-1, and XTT are hydrophilic and
membrane-impermeable anions which do not enter live cells [58]. As
reported here, cationic PMS is similarly predicted by QSAR modeling
[45] to be membrane non-permeant. Hence, the reduction of PMS must
occur outside live cells. In keeping with this, the green fluorescence of
PMS is not observed within live cells, except following the intracellular
presence of methyl-phenazine. Thus, when PMS is reduced to the
blue-fluorescing and lipophilic methyl-phenazine, this compound is
predicted to be membrane-permeant and so to passively enter the cell.
Further, as its log P value lies between 2-5, methyl-phenazine is predicted
to accumulate in lipid droplets and the Golgi apparatus [45, 47].
Accordingly, the most intense staining was that of lipid droplets, with
some paler staining of the Golgi apparatus seen. Strong, generalized
staining of biomembranes is not predicted, as the lipophilicity of
methyl-phenazine is less than 5, and the molecule is not amphiphilic.
However, the weak cytoplasmic background fluorescence could be due to
small amounts of methyl-phenazine being taken into other membranous
organelles and transfer vesicles.
The lipid droplet is a lipid storage compartment and is now consid-
ered an important cell organelle. Lipid droplets comprise a hydrophobic
core (mainly neutral triglycerides) surrounded by a phospholipid
monolayer. Staining of lipid droplets in cultured cells has been recently
reviewed [59], and some lipophilic probes such as Nile red, oil red O,
chlorophyll-oil micelles, and BODIPY derivatives are commonly used to
reveal lipid droplets in fluorescence microscopy [57]. In the case of live
cells subjected to MTT viability assays, lipid droplets are also selectively
labeled by the lipophilic MTT formazan [52, 58].
Taking into account the current interest in the study of selective
fluorochromes for lipid detection [57, 59, 60], the present results indi-
cate that, in addition to such currently available lipid probes,
methyl-phenazine can be used as a novel lipid droplet fluorochrome for5
vital labeling and redox assessing of cultured cells. As a whole, the results
reported here are relevant in the biomedical field and may contribute to
the development of experimental approaches using PMS as a fluorescent
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